MedTrace Logo

Evaluation on Visual Outcome of TMS

NCT06612190 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-09-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients with visual impairment. The main question it aims to answer is:

• Does TMS improve the visual outcome in patients who suffer from visual impairment? Researchers will compare TMS to the control group who will not receive effective TMS treatment) to see if TMS works to improve the visual outcomes of the patients.

Participants will

* Undergo TMS treatment or no effective TMS for consecutive 5 days.
* Visit the clinic once every 2 weeks for checkups and tests.

Conditions

  • Visual Impairment

Interventions

PROCEDURE

TMS

TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.

PROCEDURE

Control

The sham group will be given no real magnetic stimulation.

Sponsors & Collaborators

  • Evidence Based Cataract Study Group

    lead OTHER

Principal Investigators

  • Xiangjia Zhu · Eye and ENT Hospital of Fudan University

  • Yating Tang · Eye and ENT Hospital of Fudan University

  • Yinglei Zhang · Eye and ENT Hospital of Fudan University

  • Jiaqi Meng · Eye and ENT Hospital of Fudan University

  • Xin Liu · Eye and ENT Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-10-31
Completion
2027-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612190 on ClinicalTrials.gov